DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. GWIRP Research Highlights/News
  3. 2008 Gulf War Illness Research Program

NEWS RELEASE

Released: April 21, 2008

Department of Defense Gulf War Illness Research Program (GWIRP)
Funding Opportunities for Fiscal Year 2008 (FY08)

The FY08 Defense Appropriations Act provides $10 million for the Department of Defense Gulf War Illness Research Program. The Gulf War Illness Research Program (GWIRP) was established in fiscal year 1994 (FY94) to study the health effects of war-fighters deployed in the 1991 Persian Gulf War. The GWIRP challenges the scientific community to design innovative research that will improve the health and lives of veterans who have Gulf War Illness (GWI). This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). FY08 GWIRP Program Announcements for proposals in the following mechanisms are anticipated to be posted on Grants.gov by 7 May 2008.

Award Mechanism

Eligibility

Key Mechanism Elements

Funding

Submission Deadline

Idea Award

Investigators at all academic levels (or equivalent)

  • Supports highly innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements
  • Emphasis on innovation and impact on the field of Gulf War Illness research
  • Preliminary data are not required
  • Clinical trials are NOT appropriate for this award mechanism

  • A maximum of $200,000 for direct costs for up to a 2-year performance period, plus indirect costs as appropriate

Pre-application: July 2, 2008
5:00 p.m. Eastern time

Invitations for proposals by: August 8, 2008

Proposal: October 15, 2008
11:59 p.m. Eastern time

Investigator-Initiated Research Award

Independent investigators at any academic level (or equivalent)

  • Supports research to identify effective treatments for the complex of symptoms known as Gulf War Illness (GWI), improve its diagnosis, and better understand its pathobiology
  • Presentation of preliminary data is required. However, it does not necessarily have to come from the GWI research field.
  • Clinical trials are NOT appropriate for this award

  • A maximum of $600,000 in direct costs for up to a 3-year performance period, plus indirect costs as appropriate

Pre-application: July 2, 2008
5:00 p.m. Eastern time

Invitations for proposals by: August 8, 2008

Proposal: October 15, 2008
11:59 p.m. Eastern time

Clinical Trial Award

Investigators at all academic levels (or equivalent)

  • Supports rapid execution of Phase 0/I, Phase I, Phase I/II, or Phase II clinical trials with the potential to have a significant impact on GWI treatment or diagnosis
  • Presentation of preliminary data is required. However, it does not necessarily have to come from the GWI research field.
  • It is expected that the clinical trial will be initiated within 12 months of the award date

  • A maximum of $750,000 in direct costs for up to a 3-year performance period, plus indirect costs as appropriate

Pre-application: July 2, 2008
5:00 p.m. Eastern time

Invitations for proposals by: August 8, 2008

Proposal: October 15, 2008
11:59 p.m. Eastern time

Information in this pre-announcement is being provided to allow investigators time to plan and develop proposals. All proposals submitted must conform to the final program announcements that will be posted on Grants.gov at a later date. The number of awards anticipated is based on available funds, average cost of proposals, and the quality of proposals received. The GWIRP reserves the right to make awards in greater or lesser numbers than anticipated. Each program announcement will be available electronically for downloading from the Grants.gov website.

A pre-application is required and must be submitted through the CDMRP e-Receipt website. Effective 2007, full proposals requesting funding from the CDMRP are submitted through the federal government's single-entry portal, Grants.gov, in compliance with Public Law 106-107. Individual program announcements and required forms are also found on this website.

Requests for email notification of the program announcement release may be sent to Help@cdmrp.org. For more information about the GWIRP or other CDMRP-sponsored programs, please visit the CDMRP website.

Point of Contact: